UNLOCKING THE POTENTIAL OF HSP90

Serial Number 85043997
606

Registration Progress

Application Filed
May 20, 2010
Under Examination
Dec 14, 2010
Approved for Publication
Oct 19, 2010
Published for Opposition
Oct 19, 2010
Registered

Trademark Image

UNLOCKING THE POTENTIAL OF HSP90

Basic Information

Serial Number
85043997
Filing Date
May 20, 2010
Published for Opposition
October 19, 2010
Abandonment Date
January 20, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 20, 2014
Classes
005 042

Rights Holder

Synta Pharmaceuticals Corp.

03
Address
45 Hartwell Avenue
Lexington, MA 02421

Ownership History

Synta Pharmaceuticals Corp.

Original Applicant
03
Lexington, MA

Synta Pharmaceuticals Corp.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
Jay K. Meadway

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description
Jan 21, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 20, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 19, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2013 EX5G S SOU EXTENSION 5 GRANTED
Jun 13, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 13, 2013 EXT5 S SOU EXTENSION 5 FILED
Jun 6, 2013 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 21, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2012 EX4G S SOU EXTENSION 4 GRANTED
Dec 18, 2012 PROA I TEAS PETITION TO REVIVE RECEIVED
Dec 18, 2012 PETG O PETITION TO REVIVE-GRANTED
Dec 18, 2012 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Dec 18, 2012 NREV E NOTICE OF REVIVAL - E-MAILED
Dec 14, 2012 EXT4 S SOU EXTENSION 4 FILED
Jun 22, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2012 EX3G S SOU EXTENSION 3 GRANTED
Jun 15, 2012 PROA I TEAS PETITION TO REVIVE RECEIVED
Jun 15, 2012 PETG O PETITION TO REVIVE-GRANTED
Jun 15, 2012 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Jun 15, 2012 NREV E NOTICE OF REVIVAL - E-MAILED
Jun 14, 2012 EXT3 S SOU EXTENSION 3 FILED
Mar 23, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2012 EX2G S SOU EXTENSION 2 GRANTED
Mar 5, 2012 PROA I TEAS PETITION TO REVIVE RECEIVED
Mar 5, 2012 PETG O PETITION TO REVIVE-GRANTED
Mar 5, 2012 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 5, 2012 NREV E NOTICE OF REVIVAL - E-MAILED
Jan 17, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 16, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 14, 2011 EXT2 S SOU EXTENSION 2 FILED
May 19, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 18, 2011 EX1G S SOU EXTENSION 1 GRANTED
May 13, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
May 13, 2011 EXT1 S SOU EXTENSION 1 FILED
Dec 14, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 19, 2010 PUBO A PUBLISHED FOR OPPOSITION
Oct 19, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2010 ALIE A ASSIGNED TO LIE
Sep 15, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 3, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2010 DOCK D ASSIGNED TO EXAMINER
May 25, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for use in oncology
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
medical and scientific research, namely, conducting clinical trials; pharmaceutical research and development
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HSP90"

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO